Hemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS) following treatment with tisagenlecleucel

被引:22
|
作者
Maria Martin-Rojas, Reyes [1 ]
Gomez-Centurion, Ignacio [1 ,2 ]
Bailen, Rebeca [1 ,2 ]
Bastos, Mariana [1 ,2 ]
Diaz-Crespo, Francisco [2 ,3 ]
Carbonell, Diego [1 ,2 ]
Correa-Rocha, Rafael [2 ]
Pion, Marjorie [2 ]
Munoz, Cristina [1 ,2 ]
Sancho, Milagros [2 ,4 ]
Gomez Fernandez, Isabel [2 ,5 ]
Oarbeascoa, Gillen [1 ,2 ]
Perez-Corral, Ana [1 ,2 ]
Martinez-Laperche, Carolina [1 ,2 ]
Anguita, Javier [1 ,2 ]
Buno, Ismael [1 ,2 ,6 ,7 ]
Menarguez, Javier [2 ,3 ]
Luis Diez-Martin, Jose [1 ,2 ,7 ]
Kwon, Mi [1 ,2 ]
机构
[1] Hosp Gen Univ Gregorio Maranon, Dept Hematol, Doctor Esquerdo 46, Madrid 28007, Spain
[2] Gregorio Maranon Hlth Res Inst, Madrid, Spain
[3] Hosp Gen Univ Gregorio Maranon, Dept Pathol, Madrid, Spain
[4] Hosp Gen Univ Gregorio Maranon, Intens Care Unit, Madrid, Spain
[5] Hosp Gen Univ Gregorio Maranon, Dept Nucl Med, Madrid, Spain
[6] Hosp Gen Univ Gregorio Maranon, Genom Unit, Madrid, Spain
[7] Univ Complutense Madrid, Madrid, Spain
来源
CLINICAL CASE REPORTS | 2022年 / 10卷 / 01期
关键词
CAR T cells; hemophagocytic lymphohistiocytosis; macrophage activation syndrome; tisagenlecleucel; T-CELL THERAPY; MANAGEMENT; DIAGNOSIS; EMAPALUMAB; CHILDREN;
D O I
10.1002/ccr3.5209
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chimeric antigen receptor (CAR) T cell-related HLH/MAS is an unusual manifestation of severe cytokine release syndrome (CRS) with poor prognosis and a challenging diagnosis. The establishment of specific diagnosis criteria is essential, and the combination of several techniques for CAR T-cell follow-up, allows a more precise management of this complication.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] DIAGNOSTIC TESTING IN HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS AND MACROPHAGE ACTIVATION SYNDROME
    Lau, Michael
    Cheng, Jerry
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [22] Next Generation Sequencing Analysis of Familial Haemophagocytic Lymphohistiocytosis (HLH) Related Genes in Macrophage Activation Syndrome (MAS) and Secondary HLH (sHLH)
    Passarelli, Chiara
    Pardeo, Manuela
    Caiello, Ivan
    Pisaneschi, Elisa
    Insalaco, Antonella
    Minoia, Francesca
    Taddio, Andrea
    Licciardi, Francesco
    Novelli, Antonio
    De Benedetti, Fabrizio
    Bracaglia, Claudia
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [23] Next Generation Sequencing Analysis of Familial Haemophagocytic Lymphohistiocytosis (HLH) Related Genes in Macrophage Activation Syndrome (MAS) and Secondary HLH (sHLH)
    Passarelli, Chiara
    Pardeo, Manuela
    Caiello, Ivan
    Pisaneschi, Elisa
    Novelli, Antonio
    De Benedetti, Fabrizio
    Bracaglia, Claudia
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [24] Outcomes of an Evidence Based Guideline for the Treatment of Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome
    Hoyt, Kacie
    Halyabar, Olha
    Han, Joseph
    Case, Siobhan
    Chang, Margaret
    Platt, Craig
    Cohen, Ezra
    Day-Lewis, Megan
    Dedeoglu, Fatma
    Hausmann, Jonathan
    Janssen, Erin
    Lee, Pui
    Lo, Jeffrey
    Priebe, Gregory
    Lo, Mindy
    Meidan, Esra
    Nigrovic, Peter
    Roberts, Jordan
    Son, Mary Beth
    Sundel, Robert
    Gorman, Mark
    Degar, Barbara
    Hazen, Melissa
    Henderson, Lauren
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [25] TRADITIONAL LABORATORY PARAMETERS AND NEW BIOMARKERS IN MACROPHAGE ACTIVATION SYNDROME (MAS) AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (sHLH)
    De Matteis, A.
    Marafon, D. Pires
    Caiello, I.
    Pardeo, M.
    Marucci, G.
    Sacco, E.
    Minoia, F.
    Licciardi, F.
    Minaici, A.
    Maccora, I.
    Maggio, M. C.
    Prencipe, G.
    De Benedetti, F.
    Bracaglia, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 285 - 286
  • [26] Outcomes of an Evidence Based Guideline for the Treatment of Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome
    Hoyt, Kacie
    Halyabar, Olha
    Han, Joseph
    Case, Siobhan
    Chang, Margaret
    Cohen, Ezra
    Dedeoglu, Fatma
    Gorman, Mark
    Hausmann, Jonathan
    Janssen, Erin
    Lee, Pui
    Lo, Jeffrey
    Lo, Mindy
    Meidan, Esra
    Nigrovic, Peter
    Roberts, Jordan
    Son, Mary Beth
    Sundel, Robert
    Degar, Barbara
    Hazen, Melissa
    Henderson, Lauren
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 : 316 - 317
  • [27] Next Generation Sequencing Analysis of Familial Haemophagocytic Lymphohistiocytosis (HLH) Related Genes in Macrophage Activation Syndrome (MAS) and Secondary HLH (secHLH)
    Passarelli, Chiara
    Pardeo, Manuela
    Pisaneschi, Elisa
    Novelli, Antonio
    De Benedetti, Fabrizio
    Bracaglia, Claudia
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [28] An update on secondary haemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS) - a clinical analysis of 12 cases in Austria
    Troendle, N.
    Pircher, A.
    Magnes, T.
    Panny, M.
    Greil, R.
    Keil, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 146 - 146
  • [29] Sensitivity and Specificity of Diagnostic Guidelines for Macrophage Activation Syndrome (MAS) or Hemophagocytic Lymphohistiocytosis in children with Systemic JIA-Associated MAS
    Palmisani, Elena
    Guseinova, D.
    Davi, S.
    Dalpra, S.
    Visconti, C.
    Lattanzi, B.
    De Sanctis, S.
    Muratore, V
    Martini, A.
    Ravelli, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 460 - 460
  • [30] Blurring of the distinction between hemophagocytic lymphohistiocytosis and macrophage activation syndrome
    Cron, Randy
    Zhang, Mingce
    JOURNAL OF IMMUNOLOGY, 2013, 190